NEAUA Main Site  |  Past and Future Meetings
New England Section of the American Urological Association
Final Program

Program & Abstracts | Urology Nurses & Associates Program


THURSDAY, SEPTEMBER 12, 2019
7:00 am - 5:00 pm
REGISTRATION DESK
Ballroom Foyer
7:00 am - 5:00 pm
SPEAKER READY ROOM
Meeting Room 553
7:30 am - 8:30 am
CONTINENTAL BREAKFAST
Ballroom D/E Foyer
8:00 am - 8:15 am
INTRODUCTION & WELCOME
Ballroom D/E

Stephen F. Schiff, MD; President
New England Section of the American Urological Association

Scott K. Swanson, MD
AUA President-Elect
8:15 am - 9:35 am
SCIENTIFIC SESSION I: PROSTATE, URETHRA, PENILE, TESTIS CANCER
Ballroom D/E (6 minute presentation, 2 minute discussion)
Moderators: Mark K. Plante, MD; Steven L. Chang, MD
8:15 am - 8:23 am
1. Widespread Use Of Multiparametric MRI In An Active Surveillance Cohort Results In Earlier Identification And Treatment Of Clinically Significant Prostate Cancer
Alice Yu, MD, Andrew Gusev, BS, Timothy Baloda, BS, Eduoard Nicaise, BS, Mukesh Harisinghani, MD, Amirkasra Mojtahed, MD, Douglas Dahl, MD, Matthew Wszolek, MD, Anthony Zietman, MD, Adam Feldman, MD, MPH
Massachusetts General Hospital, Boston, MA
8:23 am - 8:31 am
2. Identifying Gene Expression to Predict Biochemical Recurrence Following Radical Prostatectomy
John Corradi, PhD, Christine Cumarasamy, MD, Ilene Staff, PhD, Joseph Tortora, MS, Andrew Salner, MD, Joseph Wagner, MD
Hartford Hospital, Hartford, CT
8:31 am - 8:39 am
3. ARCHES - Efficacy of Androgen Deprivation Therapy with Enzalutamide or Placebo in Metastatic Hormone-Sensitive Prostate Cancer: Prostate-Specific Antigen Results
Phillip Lammers, MD1, Arnulf Stenzl, MD2, Russell Z. Szmulewitz, MD3, Daniel Petrylak, MD4, Jeffrey Holzbeierlein, MD5, Arnauld Villers, MD6, Arun Azad, MD7, Antonio Alcaraz, MD8, Boris Alekseev, MD9, Taro Iguchi, MD10, Neal D. Shore, MD11, Brad Rosbrook, MD12, Benoit Baron, MD13, Futoshi Kunieda, MDS14, Robert Morlock, MD15, Krishnan Ramaswamy, MD16, Andrew J. Armstrong, MD17
1Baptist Cancer Center, Memphis, TN; 2University Hospital, Eberhard Karls University of Tübingen, Tübingen, Germany, 3The University of Chicago, Chicago, IL; 4Yale Cancer Center, New Haven, CT; 5The University of Kansas Medical Center, Kansas City, KS; 6University Hospital Centre, Lille University, Lille, France, 7Monash Health, Melbourne, Victoria, Australia, 8Hospital Clinic de Barcelona, Barcelona, Barcelona, Spain, 9Hertzen Moscow Cancer Research Institute, Moscow, Russian Federation, 10Osaka City University Graduate School of Medicine, Osaka, Japan, 11Carolina Urologic Research Center, Myrtle Beach, SC; 12Pfizer Inc., San Diego, CA; 13Astellas Pharma, Inc., Leiden, Netherlands, 14Astellas Pharma, Inc., Northbrook, IL,, IL; 15Astellas Pharma, Inc., Northbrook, IL; 16Pfizer Inc., New York, NY; 17Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC
8:39 am - 8:47 am
4. The PROSPER Trial: Prostate-Specific Antigen (PSA)- and Chemotherapy-Related Endpoints in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide
Joseph W. Kim, MD1, Cora N. Sternberg, MD2, David Penson, MD3, Neal Shore, MD4, Fred Saad, MD5, Jennifer Sugg, MD6, Joyce Steinberg, MD6, Katharina Modelska, MD7, Maha Hussain, MD8
1Yale Cancer Center, New Haven, CT; 2Weill Cornell Medicine, New York, NY; 3Vanderbilt University, Nashville, TN; 4Carolina Urologic Research Center, Myrtle Beach, SC; 5University of Montreal Hospital Centre (CHUM), Montreal, QC, QC, Canada, 6Astellas Pharma, Inc., Northbrook, IL; 7Pfizer Inc., San Francisco, CA; 8Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
8:47 am - 8:55 am
5. Need for Intervention and Survival in a Cohort of Patients on Active Surveillance for Prostate Cancer
Alice Yu, MD1, Edouard Nicaise, BS1, Timothy Baloda, BS1, Andrew Gusev, BS1, David Kuppermann, MD1, Mark Preston, MD, MPH2, Michael Blute, MD1, Douglas Dahl, MD1, Anthony Zietman, MD1, Adam Feldman, MD, MPH1
1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA
8:55 am - 9:03 am
6. Multimodal Therapy for Patients with High-Grade, High-Risk Prostate Cancer with Long-Term Followup
Jason Gee, MD; John Libertino, MD; Kaitlin Schuster, RA
Emerson Hospital, Concord, MA
9:03 am - 9:11 am
7. Clinically-Insignificant Prostate Cancer (Gleason Grade Group 1) or Benign Pathology in PI-RADS 5 Lesions with Extraprostatic Extension on Multi-Parametric MRI
Kamyar Ghabili Amirkhiz, MD, Jason Hao, MD, Sarah Amalraj, BS, Michael Leapman, MD, Jeffrey Weinreb, MD, Preston Sprenkle, MD
Yale School of Medicine, New Haven, CT
9:11 am - 9:19 am
8. Is Gadolinium Really Necessary? Moving from Multiparametric to Biparametric Prostate MRI
Benjamin T. Ristau, MD, MHA, Joseph Testa, MDc, Mary Soyster, MD, Krithika Srikanthan, MD, Marco Molina, MD, Peter C. Albertsen, MD
University of Connecticut, West Hartford, CT
9:19 am - 9:27 am
9. Clinical Risk Based Associations of Lymph Node Dissection and Detection Yield Among Men Treated with Radical Prostatectomy for Prostate Cancer
Alejandro Abello, MD, Patrick A. Kenney, MD, Preston Sprenkle, MD, Michael Leapman, MD
Yale School of Medicine, New Haven, CT
9:27 am - 9:35 am
10. Impact Of Second Generation Neoadjuvant Hormone Therapy On Radical Prostatectomy Outcomes
Alice Yu, MD1, Julie Szymaniak, MD1, Melissa Huynh, MD1, Dimitar Zlatev, MD1, Rana McKay, MD2, Mary-Ellen Taplin, MD3, Adam Kibel, MD1
1Brigham and Women's Hospital, Boston, MA, 2University of San Diego, San Diego, CA, 3Dana Farber Cancer Institute, Boston, MA
9:35 am - 10:00 am
COFFEE BREAK
Ballroom Foyer
10:00 am - 10:30 am
PANEL I: Updated Management On The Multimodal Treatment Of Upper Tract Urothelial Cancer
Ballroom D/E
Moderator: Anoop Meraney, MD
Panelists: Kriti Mittal, MD; Nicklas Oldenberg, MD; Benjamin Ristau, MD; Jesse Aronowitz, MD
10:30 am - 12:00 pm
SCIENTIFIC SESSION II: PROSTATE II
Ballroom D/E (6 minute presentation, 2 minute discussion)
Moderators: Peter T. Scardino, MD; David Canes, MD
10:30 am - 10:38 am
11. Associations of Rurality and Disease Outcome in Urologic Malignancy
Marianne Casilla-Lennon, MD, Alejandro Abello, MD, Patrick A. Kenney, MD, Michael Leapman, MD
Yale School of Medicine, New Haven, CT
10:38 am - 10:46 am
*12. Association between Tumor Multifocality on Multi-parametric MRI and Detection Rate of Clinically-Significant Prostate Cancer in Lesions with Prostate Imaging Reporting and Data System (PI-RADS) Score 4
Kamyar Ghabili Amirkhiz, MD1, Matthew Swallow, MD1, Rachael Sherrer, MD2, Jamil Syed, MD1, Michael Leapman, MD1, Soroush Rais-Bahrami, MD2, Preston Sprenkle, MD1
1Yale School of Medicine, New Haven, CT, 2University of Alabama at Birmingham, Birmingham, AL
10:46 am - 10:54 am
13. Independent Contributions of MRI Fusion and Systematic Prostate Biopsies to Detect Clinically Significant Prostate Cancer: A Multi-Institutional Review
Dylan M. Buller, BA1, Guy J. Manetti, MD2, Brandon C. Stahl, MD3, Joseph R. Wagner, MD4
1University of Connecticut School of Medicine, Farmington, CT, 2Urology Associates of Danbury, PC, Danbury, CT, 3Hartford Healthcare, William Backus Hospital, Norwich, CT, 4Hartford Healthcare, Hartford, CT
10:54 am - 11:02 am
14. Impact of MRI-Ultrasound Fusion Prostate Biopsy On Pathologic Downgrading During Radical Prostatectomy
Jeannie J. Su, MD, Kamyar Ghabili Amirkhiz, MD, Sarah Amalraj, MD, Michael Leapman, MD, Preston Sprenkle, MD
Yale, New Haven, CT
11:02 am - 11:10 am
15. Active Surveillance for Localized Prostate Cancer after Long Term Follow Up
Alex Hennessey, MD, Mary Soyster, BA, Ghali Lemtiri-Chlieh, BS, Benjamin Ristau, MD, Peter Albertsen, MD, MPH
University of Connecticut Health Center, Farmington, CT
11:10 am - 11:18 am
16. 4Kscore and mpMRI, in Combination, Safely Reduces Prostate Biopsy Rates
Stephen M. Zappala, MD1, Sanoj Punen, MD2, Badrinath Konety, MD3, Stefan Czarniecki, MD4, Ali Kasraeian, MD5, Eric Kim, MD6.
1Andover Urology, Andover, MA, 2U Miami, Miami, FL, 3Univ Minnesota, Minneapolis, MN, 4Univ Warsaw, Warsaw, Poland, 5Jacksonville Memorial Hospital, Jacksonville, FL, 6Washington University, St Louis, MO
11:18 am - 11:26 am
17. MRI Membranous Urethral Length Does Not Predict Early Return to Continence Following Robotic-Assisted Radical Prostatectomy
Liz B. Wang, MD, Hersh H. Bendre, BS, David S. Wang, MD, Richard K. Babayan, MD, Boris N. Bloch, MD, Mark H. Katz, MD
Boston Medical Center, Boston, MA
11:26 am - 11:34 am
*18. Initial Experience of MRI-Fusion Biopsy in the Community Setting
Kevin Krughoff, MD1, Lawrence Dagrosa, MD1, Amichai Kilchevsky, MD2
1Dartmouth-Hitchcock, Lebanon, NH, 2Concord Hospital, Lebanon, NH
11:34 am - 11:42 am
19. Combination of Multiparametric MRI-Ultrasound Fusion and Systematic Prostate Biopsy Results in Optimal Concordance with Final Surgical Pathology
Alice Yu, MD, Tammer Yamany, MD, Nawar Hanna, MD, Eduoard Nicaise, BS, Amirkasra Mojtahed, MD, Mukesh Harisinghani, MD, Chin-Lee Wu, MD, Douglas Dahl, MD, Matthew Wszolek, MD, Michael Blute, MD, Adam Feldman, MD
Massachusetts General Hospital, Brigham and Women's Hospital, Boston, MA
11:42 am - 11:50 am
20. Does Post Prostatectomy Decipher Score Predict PSA Recurrence and Impact Care?
Christine White, MD, Ilene Staff, PhD, Tara McLaughlin, PhD, Joseph Tortora, MS, Kevin Pinto, BS, Akshay Gangakhedkar, BS, Alison Champagne, MPH, Joseph Wagner, MD; Adnan Dervishi, MD
Hartford Hospital, Hartford, CT
11:50 am - 11:58 am
21. Laboratory Testing Following Robotic Assisted Laparoscopic Radical Prostatectomy Does Not Change Clinical Management
Ohad Kott, MD1, Osama Al-Alao, MD1, Jorge Pereira, MD2, Steven Reinert, PhD3, Christopher Tucci, RN1, Boris Gershman, MD1, Joseph Renzulli, Sr., MD4, Dragan Golijanin, MD1, Gyan Pareek, MD1
1Minimally Invasive Urology Institute, The Miriam Hospital; Department of Urology, The Warren Alpert Medical School of Brown University, Providence, RI, 2Columbia University Division of Urology, Mount Sinai Medical Center, Miami Beach, FL, 3Lifespan, Providence, RI, 4Department of urology, Yale school of Medicine, New Haven, CT
10:30 am - 11:30 am
CONCURRENT SOCIOECONOMIC SESSION
Meeting Room 551

Single Payer Health Care And Other Options: The Facts
Kevin R. Loughlin, MD
12:00 pm - 1:30 pm
CONCURRENT LUNCH SYMPOSIUM (Non-CME)
Meeting Room 551 & Meeting Room 552
1:30 pm - 2:00 pm
STATE OF THE ART LECTURE I
Ballroom D/E
Testosterone in Men With Prostate Cancer: A Generational Shift
Abraham Morgentaler, MD
2:00 pm - 3:30 pm
SCIENTIFIC SESSION III: ANDROLOGY, MEN'S HEALTH, INFERTILITY, OTHER
Ballroom D/E (6 minute presentation, 2 minute discussion)
Moderators: Katherine Rotker, MD; Martin Gross, MD
2:00 pm - 2:08 pm
VIDEO: Transurethral Resection of Ejaculatory Duct
Jared M. Bieniek, MD
2:08 pm - 2:16 pm
VIDEO: Recontruction
Alex J. Vanni, MD
2:16 pm - 2:24 pm
22. A Multi-Institutional Assessment of Multimodal Analgesia in Penile Implant Recipients Demonstrates Dramatic Narcotics Reduction
Lael Reinstatler, MD MPH1, Jacob Lucas, DO2, Martin S. Gross, MD3, Faisal A. Yafi, MD4, Farouk M. El-Khatib, MD4, Kenneth J. DeLay, MD5, Jay Simhan, MD2.
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA, 2Einstein Healthcare Network, Philadelphia, PA, USA, 3Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Keene, NH, USA, 4University of California Irvine, Orange, CA, USA, 5Advanced Urology Institute, Tallahassee, FL, USA.
2:24 pm - 2:32 pm
23. Compliance Rates for Post-Vasectomy Semen Analysis Using Laboratory Versus Home-Based Tests
James Trussler, MD, Brendan M. Browne, MD, Daneil Kuftinec, MD, Manuel Merino, MD, Andrew McCullough, MD
Lahey Hospital and Medical Center, Burlington, MA.
2:32 pm - 2:40 pm
24. Immediate Preoperative Blood Glucose and Hemoglobin A1c Levels are Not Predictive of Post-operative Infections in Diabetic Men Undergoing Penile Prosthesis Placement
Martin S. Gross, MD1, Maxwell M. Towe, MD2, Lael Reinstatler, MD MPH3, Mohamad M. Osman, MD2, Linda M. Huynh, MD2, Farouk M. El-Khatib, MD2, Gregory Broderick, MD4, Arthur L. Burnett, MD5, Amy I. Guise, MD6, Georgios Hatzichristodoulou, MD7, Jonathan Clavell-Hernandez, MD8, Gerard D. Henry, MD9, Tung-Chin Hsieh, MD10, Lawrence C. Jenkins, MD11, Aaron C. Lentz, MD12, Ricardo M. Munarriz, MD13, Daniar Osmonov, MD14, Sung Hun Park, MD15, Jay Simhan, MD16, Run Wang, MD8, Faisal A. Yafi, MD2
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Keene, NH, 2University of California Irvine, Orange, CA, 3Dartmouth-Hitchcock Medical Center, Lebanon, NH, 4Mayo Clinic-Jacksonville, Jacksonville, FL, 5Johns Hopkins University, Baltimore, MD, 6Medical College of Wisconsin, Milwaukee, WI, 7Julius-Maximilians-University of Würzburg, Würzburg, Germany, 8University of Texas Medical School at Houston, Houston, TX, 9Ark-La-Tex Urology, Shreveport, LA, 10University of California San Diego, San Diego, CA, 11Ohio State University, Columbus, OH, 12Duke University, Raleigh, NC, 13Boston University, Boston, MA, 14University Medical Center Schleswig-Holstein, Kiel, Germany, 15Sewum Urology Center of Excellence, Seoul, Korea, Republic of, 16Einstein Healthcare Network, Philadelphia, PA
2:40 pm - 2:48 pm
25. Cutting the Cord: A National Survey on Urology Resident Vasectomy Training
Mary E. Soyster, BA, Kathryn Wagner, MD, Christian Bartels, MD, Brooke A. Harnisch, MD
University of Connecticut, Farmington, CT
2:48 pm - 2:56 pm
26. The Use of Penile Computed Tomography Cavernosogram (CTC) in the Evaluation of Peyronie's Disease
Jared P. Schober, MD, Sebastian Flacke, MD, Andrew R. McCullough, MD
Lahey Hospital and Medical Center, Burlington, MA
2:56 pm - 3:04 pm
27. Adherence to the AUA Penile Prosthesis Antibiotic Prophylaxis Guidelines in Diabetic Patients is Associated with Significantly Higher Risks of Device Infection
Maxwell M. Towe, MD1, Lael Reinstatler, MD MPH2, Mohamad M. Osman, MD1, Linda M. Huynh, MD1, Farouk M. El-Khatib, MD1, Gregory Broderick, MD3, Arthur L. Burnett, MD4, Martin S. Gross, MD5, Georgios Hatzichristodoulou, MD6, Jonathan Clavell-Hernandez, MD7, Gerard D. Henry, MD8, Tung-Chin Hsieh, MD9, Lawrence C. Jenkins, MD10, Aaron C. Lentz, MD11, Ricardo M. Munarriz, MD12, Daniar Osmonov, MD13, Sung Hun Park, MD14, Jay Simhan, MD15, Run Wang, MD7, Faisal A. Yafi, MD1
1University of California Irvine, Orange, CA, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, 3Mayo Clinic-Jacksonville, Jacksonville, FL, 4Johns Hopkins University, Baltimore, MD, 5Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Keene, NH, 6Julius-Maximilians-University of Würzburg, Würzburg, Germany, 7University of Texas Medical School at Houston, Houston, TX, 8Ark-La-Tex Urology, Shreveport, LA, 9University of California San Diego, San Diego, CA, 10Ohio State University, Columbus, OH, 11Duke University, Raleigh, NC, 12Boston University, Boston, MA, 13University Medical Center Schleswig-Holstein, Kiel, Germany, 14Sewum Urology Center of Excellence, Seoul, Korea, Republic of, 15Einstein Healthcare Network, Philadelphia, PA
3:04 pm - 3:12 pm
28. Assessment of Novel Extended Manual Modeling Demonstrates Safe and Effective Reduction of Residual Penile Curvature During Penile Prosthesis Implantation
Martin S. Gross, MD1, Lael Reinstatler, MD MPH2, Jacob Lucas, DO3, Ryan Barlotta, DO3, Jay Simhan, MD3
1Dartmouth-Hitchcock Medical Center/Dartmouth-Hitchcock Keene, Keene, NH, 2Dartmouth-Hitchcock Medical Center, Lebanon, NH, 3Einstein Healthcare Network, Philadelphia, PA
3:12 pm - 3:20 pm
29. The Mulcahy Salvage revisited: a critical appraisal of antiseptic irrigation
Shu Pan, MD, Ricardo Munarriz, MD, Maria D'amico, BA
Boston Medical Center, Boston, MA
3:20 pm - 3:28 pm
30. Regional Variation in Penile Prosthesis Implantation among Medicare Patients Diagnosed with Erectile Dysfunction
Michael Rezaee, MD, MPH1, Briana Goddard, BA1, Ricardo M. Munarriz, MD, MPH2, Martin S. Gross, MD1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Boston Medical Center, Boston, MA
2:00 pm - 3:30 pm
CONCURRENT POSTER SESSION I: INCONTINENCE/OVERACTIVE BLADDER/BPH/FEMALE/RECONSTRUCTION
Rotunda (3 minute presentation, 2 minute discussion)
Moderators: Elodi Dielubanza, MD; Paula B. Bellin, MD
2:00 pm - 2:15 pm
Poster Viewing Time
2:15 pm - 2:20 pm
P1. The Use of Urethral Slings to Treat Incontinence in Elderly Women: Is it Safe?
Valary T. Raup, MD, Alexandra Berger, MD, Julie Szymaniak, MD, Steven Chang, MD, Erica Ditkoff, MD, Elodi Dielubanza, MD
Brigham and Women's Hospital, Harvard Medical School, Boston, MA
2:20 pm - 2:25 pm
P2. Intravesical Botulinum Toxin Injections for Detrusor Overactivity in Patients Suffering from Multiple Sclerosis; Appropriate Clinical Practice for Retaining this Population
Michael E. Goltzman, MD1, Brendan Gontarz, MD2, Gerard Pregenzer, MD2
1UConn Health, Farmington, CT, 2Saint Francis Hospital and Medical Center, Hartford, CT
2:25 pm - 2:30 pm
P3. The Role of Anesthesia in Urinary Retention Following Mid Urethral Sling
Eric Katz, MD, Kareem Alazem, MD, Kristian Stensland, MD, Lara MacLachlan, MD
Lahey Hospital and Medical Center, Burlington, MA
2:30 pm - 2:35 pm
P4. Green Light Laser Enucleation of the Prostate (GLEP) with Lasting Outcomes: Longer-Term Follow-up
Tammer Yamany, MD, Carlos Mejia, BS, Kai Li, MD, Alan Yaghoubian, MD, Mahdi Zangi, MD, Bo Wu, MD, Shahin Tabatabaei, MD
Massachusetts General Hospital, Boston, MA
2:35 pm - 2:40 pm
P5. WITHDRAWN
2:40 pm - 2:45 pm
P6. Comparison of Transabdominal and Transrectal Ultrasound for Sizing of the Prostate
Wesley R. Pate, MD, Nishant Garg, BS, Liz B. Wang, MD, Shaun E. Wason, MD, Philip V. Barbosa, MD
Boston University Medical Center, Boston, MA
2:45 pm - 2:50 pm
P7. WITHDRAWN
2:50 pm - 2:55 pm
P8. Cost-Effectiveness Analysis of Autologous versus Allograft Pubovaginal Slings
Michal Ursiny, MD, Ajay K. Singla, MD
Massachusetts General Hospital, Boston, MA
2:55 pm - 3:00 pm
P9. Testing for Racial Sampling Bias in the National Cancer Database: Does the NCDB Adequately Represent Racial Minorities with Genitourinary Cancers?
Kyle Michelson, BA1, Danielle Gordon, BS1, Tashzna Jones, BS1, Thomas Monaghan, BS1, Raymond Khargi, MD1, Matthew Smith, MD1, Fenizia Maffucci, BS1, Hyezo Kwun, BS1, Nicholas Suss, BS1, Andrew Winer, MD2
1SUNY Downstate Medical Center, Department of Urology, Brooklyn, NY, 2Kings County Hospital, Department of Urology, Brooklyn, NY
3:00 pm - 3:05 pm
P10. ProTouch Laser Enucleation of the Prostate: A retrospective analysis of the first 77 cases
Michael Emmerling, BS, Wesley Pate, MD, Shaun Wason, MD
Boston University School of Medicine, Boston, MA
3:05 pm - 3:10 pm
P11. A Comparison of Pre- and Post-Operative Bladder/Bowel Symptoms Among Patients Undergoing Complete Surgical Endometriosis Resection
Rachael Mazzamurro-Romer, BA1, Chung Hwa YI, MD2, Veronica Triaca, MD2
1Geisel School of Medicine at Dartmouth, Hanover, NH; 2Concord Hospital, Concord, NH
3:10 pm - 3:15 pm
*P12. Predictors of Index Surgical Care Setting during Penile Prosthesis Surgery: Impact on Perioperative Outcomes and Cost
Alexandra Berger, MD, David Friedlander, MD, Martin Kathrins, MD, Quoc-Dien Trinh, MD
Brigham and Women's Hospital/Harvard University, Boston, MA
3:30 pm - 3:50 pm
COFFEE BREAK
Ballroom Foyer
3:50 pm - 4:00 pm
AUA Core Curriculum Update
Ballroom D/E
4:00 pm - 4:15 pm
Research Scholar Award
Ballroom D/E
Obesity and Inflammatory Mediators Modulate Prostatic Growth by Regulating Aromatase Activity
Zongwei Wang, MD
4:15 pm - 5:00 pm
PANEL II: Multidisciplinary Management of Chronic Pelvic Pain
Ballroom D/E
Moderator: Veronica Triaca, MD
Panelists: Linda Ng, MD; Arthur P. Mourtzinos, MD; Lara Maclachlan, MD; E. Ann Gormley, MD; Kelley Hamil Lemay, APRN
5:00 pm - 5:30 pm
PANEL III: What is New in Uroradiology for Benign and Malignant Disease
Ballroom D/E
Moderator: Timothy Y. Tran, MD
Panelists: Richard Noto, MD; Khashayar Rafatzand, MD; Francis J. McGovern, MD; Aoife Kilcoyne, MD
5:30 pm - 7:00 pm
WELCOME RECEPTION IN EXHIBIT HALL
Ballroom A

FRIDAY, SEPTEMBER 13, 2019
6:30 am – 8:00 am
BREAKFAST SYMPOSIUM (Non-CME)
Meeting Room 551
7:30 am - 5:00 pm
REGISTRATION DESK
Ballroom Foyer
7:30 am - 5:00 pm
SPEAKER READY ROOM
Meeting Room 553
7:30 am - 8:30 am
CONTINENTAL BREAKFAST, VISIT EXHIBITS
Ballroom A
7:30 am - 12:30 pm
EXHIBIT HALL
2:00 pm - 6:30 pm
Ballroom A
8:00 am - 12:00 pm
HOSPITALITY SUITE
South County (Omni Hotel)
8:00 am - 8:30 am
PANEL IV: An Update in Trauma: Preparing for the Midnight Call and Beyond
Ballroom D/E
Moderator: David S. Wang, MD
Panelists: Liza M. Aguiar, MD; Kennon S. Miller, MD; Rachel A. Moses, MD; Ulises Torres, MD
8:30 am - 10:00 am
SCIENTIFIC SESSION IV: BLADDER, PROSTATE, KIDNEY
Ballroom D/E (6 minute presentation, 2 minute discussion)
Moderators: Jesse D. Sammon, MD; Andrew A. Wagner, MD
8:30 am - 8:38 am
Video: Extended Pelvic Node Dissection in Prostate Cancer
Joseph R. Wagner, MD
8:38 am - 8:46 am
Video: Intracorporeal Ileal Conduit
Ryan Dorin, MD
8:46 am - 8:54 am
31. "I don't know what a nomogram is": A mixed methods approach to the creation of a patient decision aid for men with high-risk features post prostatectomy
Jesse D. Sammon, D.O., Christina R. Gentile, BS, Michael Kohut, Ph.D., Christopher Stockdale, MD, Moritz Hansen, MD, Paul Han, MD
Maine Medical Center, Portland, ME, USA.
8:54 am - 9:02 am
*32. Re-Examining An Old Trend: The Association of Human Papillomavirus and Bladder Cancer
Lael Reinstatler, MD, MPH1, Kevin Shee, PhD1, Krisitian Stensland, MD, MPH2, Lawrence Dagrosa, MD1, John Seigne, MB1, Einar F. Sverrisson, MD1
1Dartmouth Hitchcock Medical Center, Lebanon, NH, 2Lahey Clinic, Burlington, MA
9:02 am - 9:10 am
33. Fascial Anastomosis Suspension Technique (FAST) During Open Retropubic Radical Prostatectomy: A Novel Method to Improve Early Postoperative Recovery of Urinary Continence
Alessandra Ambu, MD, Stefano Guercio, MD, Marco Russo, MD, Mariateresa Carchedi, MD, Antonino Battaglia, MD, Giulio Bonvissuto, MD, Maurizio Bellina, MD
Ospedale degli Infermi di Rivoli - ASL TO3, Rivoli, Italy
9:10 am - 9:18 am
34. Early Stable Disease after Cytoreductive Nephrectomy is a Benchmark for Long Term Outcomes
Alice Yu, MD, Edouard Nicaise, BS, Melissa Huynh, MD, Douglas Dahl, MD, Matthew Wszolek, MD, Adam Feldman, MD, Michael Blute, MD
Massachusetts General Hospital, Boston, MA
9:18 am - 9:26 am
35. Building a Program in Robot-Assisted Radical Cystectomy with Intracorporeal Ileal Conduit
Adrian J. Waisman Malaret, MD, Sara Hyde, BS, Lauren Dewey, PhD, Kimberly Taylor, BS, Kyle McAnally, BS, Catrina Crociani, MPH, Andrew A. Wagner, MD, Peter Chang, MD, MPH
Beth Israel Deaconess Medical Center, Boston, MA
9:26 am - 9:34 am
36. A Comprehensive Pan-Cancer Gene Expression And Drug Sensitivity Analysis Reveals Slfn11 As A Marker Of Sensitivity To Dna-Damaging Chemotherapy
Kevin Shee, PhD1, Lael S. Reinstatler, MD, MPH2, John D. Seigne, MD2, Todd W. Miller, PhD1
1Geisel School of Medicine at Dartmouth, Lebanon, NH, 2Dartmouth Hitchcock Medical Center, Lebanon, NH
9:34 am - 9:42 am
9:42 am - 9:50 am
38. Assessing the Learning Curve for Robotic Assisted Laparoscopic Intracorporeal Urinary Diversion- Initial Experience and Outcomes
Keith O'Brien, MD1, Ryan Dorin, MD2
1University of Connecticut, West Hartford, CT, 2The Hospital of Central Connecticut, West Hartford, CT
9:50 am - 9:58 am
39. Institutional Review Of Open Versus Laparoscopic Partial Nephrectomy For Surgical Treatment Of Renal Cell Carcinoma
Edouard Nicaise, BS, Adam S. Feldman, MD, Alice Yu, MD, Yichuan G. Hsieh, PhD, Naren Nimmagadda, MD, Francis J. McGovern, MD, Matthew Wszolek, MD, Michael L. Blute, MD, Douglas M. Dahl, MD
Massachusetts General Hospital, Boston, MA
10:00 am - 10:30 am
COFFEE BREAK, VISIT EXHIBITS
Ballroom A
10:30 am - 11:00 am
PANEL V: Complex Stone Cases
Ballroom D/E
Moderator: Vernon M. Pais, MD
Panelists: Kevan Sternberg, MD; Diane Sacco, MD: Priuz Motamedinia, MD; Margaret Pearle, MD; Brian H. Eisner, MD
11:00 am - 12:30 pm
SCIENTIFIC SESSION V: STONE DISEASE
Ballroom D/E (6 minute presentation, 2 minute discussion)
Moderators: Jessica A. Mandeville, MD; Ruslan Korets, MD
11:00 am - 11:08 am
VIDEO: Mini PCNL
Timothy Y. Tran, MD
11:08 am - 11:14 am
40. The Utility and Value of Immersive Virtual Reality Simulation for Percutaneous Nephrostomy Tract Access and Surgical Training
Sehar Resad, MS, Egor Parkhomenko, MD, David S. Wang, MD, Shaun E. Wason, MD.
Boston University School of Medicine, Boston, MA
11:14 am - 11:22 am
41. Active Surveillance Stone Protocol Reduces Endourologic Interventions
Alejandra Balen, MD1, Ohad Kott, MD1, Osama Al-Alao, MD1, Eric Jung, MD1, Timothy O'Rourke, MD1, Meredith Wasserman, MD1, Christopher Tucci, RN1, Jie Tang, MD2, Gyan Pareek, MD1
1Minimally Invasive Urology Institute, The Miriam Hospital; Department of Urology, The Warren Alpert Medical School of Brown University, Providence, RI, 2Department of Medicine (Nephrology), The Warren Alpert Medical School of Brown University, Providence, RI
11:22 am - 11:30 am
42. Impact of a Multidisciplinary Kidney Stone Prevention Clinic
Kevin Krughoff, MD1, Cassandra Delude, APRN2, Kathy Burzynski, RD2, Scott Fabozzi, MD3
1Dartmouth-Hitchcock, Lebanon, NH, 2Concord Hospital, Concord, NH, 3Concord Hospital, Lebanon, NH
11:30 am - 11:38 am
43. Creation and initial implementation of the D.I.R.E.C.T Pathway (Delayed Imaging to Reduce Excessive Computed Tomography) for the evaluation of patients with suspected renal colic
Kevan M. Sternberg, MD, David W. Sobel, MD, Aaron Greenspun, BS, Roz Bidad, BSN, Peter Weimersheimer, MD
University of Vermont, Burlington, VT
11:38 am - 11:46 am
44. Dusting is Efficacious and Safe with a 30-Watt Laser
Eric Jung, MD, Ohad Kott, MD, Osama Al-Alao, MD, Alejandra Balen, MD, Timothy O'Rourke, MD, Meredith Wasserman, MD, Christopher Tucci, RN, Gyan Pareek, MD
Minimally Invasive Urology Institute, The Miriam Hospital; Department of Urology, The Warren Alpert Medical School of Brown University, Providence, RI
11:46 am - 11:54 am
*45. Informing the Management of Asymptomatic Nephrolithiasis: Markov Decision Analysis for the 1cm Renal Stone
Robin Djang, MD, Vernon M. Pais, MD
Dartmouth Hitchcock Medical Center, Lebanon, NH
11:54 am - 12:02 pm
46. The Effect of Holmium Laser Fiber Bending Radius on Power Delivery During Flexible Ureteroscopy
Dylan Heckscher, AB1, Junjie Zeng, BS2, Panagis Samolis, BS2, Michelle Y. Sander, PhD3, Shaun Wason, MD4, David S. Wang, MD4
1Boston University School of Medicine, Boston, MA, 2Boston University Department of Electrical and Computer Engineering and BU Photonics Center, Boston, MA, 3Boston University Department of Electrical and Computer Engineering and BU Photonics Center, Boston, MA; Boston University Division of Materials Science and Engineering, Brookline, MA, 4Boston University School of Medicine/Boston Medical Center, Boston, MA
12:02 pm - 12:10 pm
47. Beyond Prevalence: Incidence Rates For Kidney Stones In The United States
Gina N. Tundo, MD1, William Meeks, MA2, Vernon Pais, MD1
1Dartmouth Hitchcock, Lebanon, NH, 2American Urological Association, Linthicum, MD
12:10 pm - 12:18 pm
48. Who Will Follow Up? Predictors of Compliance with Nephrolithiasis Follow up After Emergency Room Visits
Brandon S. Childs, MD1, Roger B. Davis, ScD2, Ruslan Korets, MD2, Peter L. Steinberg, MD2
1Lahey Hospital and Medical Center, Burlington, MA, 2Beth Israel Deaconess Medical Center, Boston, MA
12:18 pm - 12:26 pm
49. Nephrolithiasis is Associated with Depression in US Adults: an NHANES Analysis
Lael Reinstatler, MD, MPH, Vernon Pais, MD; Briana Goddard, BA
Dartmouth Hitchcock Medical Center, Lebanon, NH
11:00 am - 12:30 pm
CONCURRENT POSTER SESSION II: GENERAL UROLOGY/BEST PRACTICES
Rotunda (3 minute presentation, 2 minute discussion)
Moderators: Shaun N. Wason, MD; Simone Thavaseelan, MD
11:00 am - 11:15 am
Poster Viewing Time
11:15 am - 11:20 am
P13. George Langstaff (1780-1846): Surgeon, Pathologist, Museum Curator, and the First to Observe Prostate Cancer during Post-Mortem Examination
Kamyar Ghabili Amirkhiz, MD1, Sasha Druskin, MD2, Jeffrey Tosoian, MD3, Michael Leapman, MD1, Christian Pavlovich, MD2, Ashley Ross, MD, PhD2, Preston Sprenkle, MD1
1Yale School of Medicine, New Haven, CT, 2The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, 3University of Michigan, Ann Arbor, MI
11:20 am - 11:25 am
P14. Characterization of U.S. Urology Resident Opioid Prescription Patterns
Gianpaolo Carpinito, BA1, Shanta Shepherd, MD2, David S. Wang, MD2, Mark H. Katz, MD2, Shaun Wason, MD2
1Boston University School of Medicine, Wellesley, MA, 2Boston University Medical Center Dept. Urology, Boston, MA
11:25 am - 11:30 am
P15. A Retrospective Evaluation of a Novel Perioperative Opioid Sparing Protocol for Patients Undergoing Robotic Assisted Laparoscopic Surgery
Joseph F. Renzulli, MD1, Henry Cabrera, MD2, Lisa Rameaka, MD2, Christina Procaccianti, PharmD3, David Krok, PharmD4
1Yale, New Haven, RI, 2South County Hospital, Wakefield, RI, 3South County, Wakefield, RI, 4URI, Kingston, RI
11:30 am - 11:35 am
P16. Do AUA Guidelines Stand on the Shoulders of Giants, or Data?
Matthew Moynihan, MD, MPH, Kristian Stensland, MD, MPH
Lahey Hospital and Medical Center, Burlington, MA
11:35 am - 11:40 am
P17. Effect of diagnostic biopsy practice location on grade/volume reclassification in active surveillance for prostate cancer: A multicenter analysis from the Canary PASS cohort
Adrian J. Waisman Malaret, MD1, Peter Chang, MD, MPH1, Catrina Crociani, MPH1, Kyle McAnally, BS1, Lisa Newcomb, PhD2, Daniel W. Lin, MD3, Anna Faino, BS4, Yingye Zheng, PhD2, Michael Garcia, MS2, James D. Brooks, MD5, Atreya Dash, MD3, Christopher Filson, MD6, Martin Gleave, MD7, Michael Liss, MD8, Frances Martin, MD9, Todd Morgan, MD10, Peter Carroll, MD, MPH11, Peter Nelson, MD2, Adrew A. Wagner, MD1
1Beth Israel Deaconess Medical Center, Boston, MA, 2Fred Hutchinson Cancer Research Center, Seattle, WA, 3University of Washington, Seattle, WA, 4Seattle Children's Research Institute, Seattle, WA, 5Stanford University, Stanford, CA, 6Emory University, Atlanta, GA, 7University of British Columbia, Vancouver, BC, Canada, 8University of Texas Health Sciences Center, San Antonio, TX, 9Urology of Virginia, Virginia Beach, VA, 10University of Michigan, Ann Arbor, MI, 11University of California, San Francisco, San Francisco, CA
11:40 am - 11:45 am
P18. Recent Trends in Receipt of Palliative Care for Men with Metastatic Prostate Cancer
Alexander P. Cole, MD1, Sean Fletcher, MD2, Zara Cooper, MD1, Stuart Lipsitz, ScD1, Adam Kibel, MD1, Quoc-Dien Trinh, MD3
1Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 2Harvard Medical School, Boston, MA, 3Brigham & Women's Hospital, Harvard Medical School, Brookline, MA
11:45 am - 11:50 am
P19. Endourology Survey on Radiation Exposure Reveals A Need for Clear Guidelines for Post Ureteroscopy Imaging
Ohad Kott, MD1, Osama Al-Alao, MD1, Jorge Pereira, MD2, Christopher Tucci, RN1, Gyan Pareek, MD1
1Minimally Invasive Urology Institute, The Miriam Hospital; Department of Urology, The Warren Alpert Medical School of Brown University, Providence, RI, 2Columbia University Division of Urology, Mount Sinai Medical Center, Miami Beach, FL
1:50 am - 11:55 am
P20. Continued Feasibility and Success of a Non-Opioid Pathway for Postoperative Pain after Ureteroscopy
David W. Sobel, MD, Nikolas A. Moring, MS, Mohannad A. Awad, MD, Kevan M. Sternberg, MD
University of Vermont, Burlington, VT
11:55 am - 12:00 pm
*P21. Incidence and Predictors of Repeated and Prolonged Opioid Prescriptions After Kidney Stone Event
Annah J. Vollstedt, MD1, WIlliam Meeks, MA2, Aeint Ngon, MA2, Brian Sites, MD, MS1, Vernon Pais, Jr., MD, MS1
1Dartmouth Hitchcock Medical Center, Lebanon, NH, 2American Urological Association, Department of Data Management and Statistical Analysis, Linthicum, MD
12:00 pm - 12:05 pm
P22. Economic Trends of Endourologic Surgery Reimbursement Demonstrates Increased Profitability for Healthcare Systems
Ohad Kott, MD, Christopher Tucci, RN, Gyan Pareek, MD
Minimally Invasive Urology Institute, The Miriam Hospital; Department of Urology, The Warren Alpert Medical School of Brown University, Providence, RI
12:05 pm - 12:10 pm
P23. Economic Evaluation of Stentless vs. Stented Uncomplicated Ureteroscopy and Laser Lithotripsy
Tammer Yamany, MD, Michal Ursiny, MD, Brian H. Eisner, MD
Massachusetts General Hospital, Boston, MA
12:10 pm - 12:15 pm
P24. Ureteral Stenting After Routine Ureteroscopy: Is Earlier Stent Removal Feasible?
Stephen C. Hill, BA1, Alexander Boyko, BA1, Samir Merheb, BS1, Michelle Hsu, BS2, Mark Biebel, MD3, Mark H. Katz, MD3, Richard K. Babayan, MD3, Shaun E. Wason, MD3, David S. Wang, MD3
1Boston University School of Medicine, Boston, MA, 2Boston University School of Public Health, Boston, MA, 3Boston Medical Center, Department of Urology, Boston, MA
12:15 pm - 12:20 pm
P25. Factors associated with Patient No-show Appointments in Community Urology Practice
Ian T. Clark, MPH, CSPPM, Joseph Renzulli, MD, FACS, Lisa Rameaka, MD, FACOG
South County Health, Wakefield, RI
12:20 pm - 12:25 pm
P26. Chasing the Pack: Association Between Urology Hospital Rankings and Surgical Outcomes
Alejandro Abello, MD, Michael Leapman, MD, Patrick A. Kenney, MD
Yale School of Medicine, New Haven, CT
12:25 pm - 12:30 pm
P27. Kidney stones in black women in the United States: Data from the Black Women's Health Study
Maria J. D'Amico, BA1, Shaun Wason, MD2, Lynn Rosenberg, ScD3, Yvette Cozier, DSc3
1Boston University School of Medicine, Boston, MA, 2Boston Medical Center, Boston, MA, 3Boston University School of Public Health, Boston, MA
12:30 pm - 2:00 pm
CONCURRENT LUNCH SYMPOSIUM (Non-CME)
Meeting Room 551 & Meeting Room 552
2:00 pm - 2:30 pm
STATE OF THE ART LECTURE II
Ballroom D/E
Changing Trends in Endourological Management of Stones
Margaret Pearle, MD
2:30 pm - 3:30 pm
AUA Course of Choice - Active Surveillance
Ballroom D/E
Laurence H. Klotz, MD
3:30 pm - 4:00 pm
COFFEE BREAK, VISIT EXHIBITS
Ballroom A
4:00 pm - 5:00 pm
SOCIOECONOMIC SESSION
Incorporating APPs into Urologic Practice

Ballroom D/E
Moderator: Gregory S. Adey, MD
Panelists: E. Ann Gormley, MD; Susan E.D. Palmer, PA; Jennifer McKenzie; NP; Karim J. Hamawy, MD
5:00 pm - 6:30 pm
ATTENDEE RECEPTION IN EXHIBIT HALL
Ballroom A
6:30 pm - 8:00 pm
RESIDENT PROGRAM
Meeting Room 551
Chair: Benjamin T. Ristau, MD

SATURDAY, SEPTEMBER 14, 2019
6:30 am - 7:30 am
WOMEN IN UROLOGY
Meeting Room 551
Career Navigation (and re-Navigation)

Leslie M. Rickey, MD
7:00 am - 3:00 pm
REGISTRATION DESK
Ballroom Foyer
7:00 am - 3:00 pm
SPEAKER READY ROOM
Meeting Room 553
7:00 am - 8:00 am
CONTINENTAL BREAKFAST, VISIT EXHIBITS
Ballroom A
7:00 am - 10:30 am
EXHIBIT HALL
Ballroom A
7:30 am - 8:00 am
ANNUAL BUSINESS MEETING, Members Only
Ballroom D/E
8:00 am - 12:00 pm
HOSPITALITY SUITE
South County (Omni Hotel)
8:00 am - 8:30 am
PANEL VI: What Is New In the Management of Muscle Invasive Bladder Cancer
Ballroom D/E
Moderator: Peter Chang
Panelists: Anthony Mega, MD; Adam S. Feldman, MD; Joseph R. Wagner, MD
8:00 am - 10:00 am
8:30 am - 10:00 am
SCIENTIFIC SESSION VI: BLADDER AND KIDNEY CANCER
Ballroom D/E (6 minute presentation, 2 minute discussion)
Moderators: Harras Zaid, MD; Benjamin Ristau, MD
8:30 am - 8:38 am
50. WITHDRAWN
8:38 am - 8:46 am
51. MicroRNA let-7f-5p Is A Novel Biomarker Of Recurrence And A Potential Therapeutic Opportunity In Non-Muscle Invasive Bladder Cancer
Kevin Shee, PhD1, Margaret R. Karagas, PhD1, Carmen J. Marsit, PhD1, Alan R. Schned, MD2, Jason R. Pettus, MD2, David Armstrong, BS1, Todd W. Miller, PhD1, John D. Seigne, MD2, Angeline S. Andrew, PhD1
1Geisel School of Medicine at Dartmouth, Lebanon, NH, 2Dartmouth Hitchcock Medical Center, Lebanon, NH
8:46 am - 8:54 am
52. The Impact Of Frequent Cystoscopy On Surgical Care And Cancer Outcomes Among Patients With Low-Risk Non-Muscle-Invasive Bladder Cancer
Florian R. Schroeck, MD, MS1, Kristine E. Lynch, PhD2, Zhongze Li, MS3, Todd A. MacKenzie, PhD3, David S. Han, MS1, John D. Seigne, MBBCh4, Douglas J. Robertson, MD, MPH1, Brenda Sirovich, MD, MS1, Philip P. Goodney, MD, MS1
1White River Junction VA Medical Center and and Geisel School of Medicine at Dartmouth, White River Junction, VT, 2VA Salt Lake City Healthcare System and University of Utah, Salt Lake City, UT, 3Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, 4Section of Urology at DHMC and Geisel School of Medicine at Dartmouth, Lebanon, NH
8:54 am - 9:02 am
53. Outcomes of Pathologic Upstaging of Clinical T1b and T2 Renal Cell Carcinoma
Melissa J. Huynh, MD, Douglas M. Dahl, MD, MPH, Edouard Nicaise, BA, Naren Nimmagadda, MD, MPH, Alice X. Yu, MD, Yichuan Hsieh, PhD, Michael L. Blute, MD, Adam S. Feldman, MD, MPH
Massachusetts General Hospital, Boston, MA
9:02 am - 9:10 am
54. Rate of Upstaging in Variant Histology Nonmuscle Invasive Bladder Cancer: Is There Evidence to Support the AUA Guidelines "Expert Opinion"?
Kristian Stensland, MD, MPH, David Canes, MD, Harras Zaid, MD
Lahey Hospital and Medical Center, Burlington, MA
9:10 am - 9:18 am
55. The Impact Of Low- Versus High-Intensity Surveillance Cystoscopy On Surgical Care And Cancer Outcomes In Patients With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Michael E. Rezaee, MD, MPH1, Kristine E. Lynch, PhD2, Zhongze Li, MS3, Todd A. MacKenzie, PhD3, John D. Seigne, MBBCh1, Douglas J. Robertson, MD, MPH4, Brenda Sirovich, MD, MS5, Philip P. Goodney, MD, MS4, Florian R. Schroeck, MD, MS4
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2University of Utah, Salt Lak City, UT, 3Geisel School of Medicine, Hanover, NH, 4Veterans Affairs Medical Center, White River Junction, VT, 5Veterans Affairs Medical Center, White River Junction, VT
9:18 am - 9:26 am
56. Renal Mass Biopsy for Cystic Renal Masses: Can We Challenge the Dogma?
Tammer Yamany, MD, Aileen O'Shea, MD, David Kuppermann, MD, Dimitar Zlatev, MD, Mukesh Harisinghani, MD, Ron Arellano, MD, Adam Feldman, MD
Massachusetts General Hospital, Boston, MA
9:26 am - 9:34 am
57. The Impact of Insurance Status on Outcomes for Bladder Cancer
Alexander P. Cole, MD1, Sean Fletcher, BS2, Chang Lu, MS3, Marieke Krimphove, MD4, Stuart Lipsitz, ScD1, Quoc-Dien Trinh, MD1
1Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 2Harvard Medical School, Boston, MA, 3Harvard School of Public Health, Boston, MA, 4University of Frankfurt, Frankfurt, Germany
9:34 am - 9:42 am
58. Premature Termination of Genitourinary Cancer Trials: Assessing Trial Efficiency Using Novel Algorithms
Kristian Stensland, MD, MPH1, Krystal DePorto, BS2, James Ryan, BS2, Matthew Galsky, MD3
1Lahey Hospital and Medical Center, Burlington, MA, 2Tufts University School of Medicine, Boston, MA, 3Icahn School of Medicine at Mount Sinai, New York, NY
9:42 am - 9:50 am
59. Contemporary Data on Incidence, Treatments and Outcomes of Tis, High-Grade Ta, and High-Grade T1 Non-Muscle Invasive Bladder Cancer Patients in the US
Jinlin Song, PhD1, Mihaela V. Georgieva, PhD2, Iryna Bocharova, BA2, Eric Wu, PhD2, Amy Guo, PhD3, Sam Spigelman, MD3, Ashish M. Kamat, MD4
1Analysis Group, Inc., Los Angeles, CA, 2Analysis Group, Inc., Boston, MA, 3Ferring Pharmaceuticals, Parsippany, NJ, 4Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX
9:50 am - 9:58 am
60. Workplace Absenteeism Following Robotic and Open Kidney Surgery
Alexander P. Cole, MD1, Daniel Pucheril, MD1, Xi Chen, MS1, Prokar Dasgupta, MBBS2, Quoc-Dien Trinh, MD1
1Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 2Faculty of Life Sciences and Medicine, Kings College London, London, United Kingdom
10:00 am - 10:30 am
COFFEE BREAK, VISIT EXHIBITS
Ballroom A
10:30 am - 11:15 am
PRESENTATION OF JOSEPH B. DOWD AWARD

LEADBETTER LECTURE
Prostate Cancer: A Perspective
The Right Treatment for the Right Cancer at the Right

Ballroom D/E
Peter T. Scardino, MD
11:15 am - 11:30 am
PRESIDENTIAL UPDATE
Ballroom D/E
Stephen F. Schiff, MD
11:30 am - 11:45 am
AUA GUIDELINES: Opioid White Paper
Ballroom D/E
Susan E.D. Palmer, PA
11:45 am - 12:30 pm
PANEL VII: The Opioid Crisis: Strategies for Surgeons to Reduce Opioid Use and Enhance Recovery after Surgery
Ballroom D/E
Panelists: Richard Urman, MD; Francis McGovern, MD; Michael J. Worley, Jr., MD
12:30 pm - 1:30 pm
LUNCH
Ballroom D/E Foyer
12:00 pm -3:30 pm
1:30 pm - 2:15 pm
STATE OF THE ART LECTURE III
Absence of 5-alpha Reductase in Adult Prostate: Opportunities for Personalized Care

Ballroom D/E
Aria F. Olumi, MD
2:15 pm - 2:55 pm
SCIENTIFIC SESSION VII: PEDIATRICS, TRAUMA, RECONSTRUCTION
Ballroom D/E (6 minute presentation, 2 minute discussion)
Moderators: Joseph McQuaid, MD; Alex Vanni, MD
2:15 pm - 2:23 pm
61. Characteristics and Clinical Outcomes of a Multi-Institutional Observational Patient Cohort Who Underwent Anastomotic Posterior Urethroplasty by a Combined Robotic Transabdominal and Open Transperineal Approach
Jaime A. Cavallo, MD, MPHS1, Alex J. Vanni, MD1, Geolani Dy, MD2, Sabrina Stair, MD2, David Canes, MD1, Lee Zhao, MD, MS2
1Lahey Hospital and Medical Center, Burlington, MA, 2New York University Langone Medical Center, New York, NY
2:23 pm - 2:31 pm
*62. Urothelial Cell Carcinoma of the Bladder in Pediatric Patients: A Systematic Review of Case Reports & Case Series
Michael E. Rezaee, MD, MPH1, Charlene M. Dunaway, PhD2, Michael L. Baker, MD1, Frank J. Penna, MD1, David R. Chavez, MD1
1Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2Geisel School of Medicine at Dartmouth, Hanover, NH
2:31 pm - 2:39 pm
63. Characteristics and Clinical Outcomes of an Observational Patient Cohort Who Underwent Buried Penis Repair
Jaime A. Cavallo, MD, MPHS1, Daniele Abela, BS2, Rafael D. Tua-Caraccia, BA2, Elizabeth J. Pagura, BA3, Alex J. Vanni, MD1
1Lahey Hospital and Medical Center, Burlington, MA, 2Tufts University School of Medicine, Boston, MA, 3Tufts University, Medford, MA
2:39 pm - 2:47 pm
64. Safety of Urethroplasty in the Comorbid Population
Gina N. Tundo, MD1, Andrew Peterson, MD2; Ramiro Madden-Fuentes, MD3
1Dartmouth Hitchcock, Lebanon, NH; 2Duke University, Durham, NC; 3Concord Hospital, Concord, NH
2:47 pm - 2:55 pm
65. The History of the Use of Colonic Muscosa in Urethral Reconstruction
Jaime A. Cavallo, MD, MPHS1, Elizabeth J. Pagura, BA2, Leonard N. Zinman, MD1, Alex J. Vanni, MD1
1Lahey Hospital and Medical Center, Burlington, MA, 2Tufts University, Medford, MA
3:00 pm - 3:30 pm
PANEL VIII: The Transition to Multimodal Treatment for Prostate Cancer
Ballroom D/E
Moderator: Mitchell H. Sokoloff, MD
Panelists: Preston Sprenkle, MD; Joseph R. Wagner, MD; Anthony Mega, MD
3:30 pm - 4:30 pm
CONCURRENT SOCIOECONOMIC SESSION
Meeting Room 551

The State of Urologic Practice in New England
Deepak A. Kapoor, MD
4:30 pm
ADJOURN
6:00 pm - 9:00 pm
PRESIDENT'S BANQUET
Rhode Island School of Design Museum

*Max K. Willscher Award Eligible